Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
San Francisco reports record low number of new HIV diagnoses

Researchers in San Francisco identified 223 new HIV diagnoses in 2016 — the lowest ever recorded in the city. Meanwhile, treatment coverage and viral suppression rates were at an all-time high.

Published
13 November 2017
From
Healio
No transmissions from breastfeeding in Tanzania cohort from mothers with undetectable viral load

No HIV exposed infants who were negative at birth, whose mothers started ART before delivery, had suppressed viral loads and exclusively breastfed, were HIV positive after breastfeeding, in a rural African cohort.

Published
13 November 2017
From
HIV i-Base
Up to a quarter of HIV-negative gay men attending three English clinics used PrEP in the last year

A prospective cohort study of gay men attending three clinics in southern England – 56 Dean Street and Mortimer Market Centre in London and the Brighton &

Published
13 November 2017
By
Gus Cairns
Danish court invalidates Gilead SPC

The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. On October 26, the court rejected Gilead’s motion for an injunction against generics maker Accord.

Published
10 November 2017
From
Life Sciences Intellectual Property Review
Trump administration begins to confront the opioid crisis

As the Presidential Commission releases its recommendations, Trump moves closer to defining his policies against the opioid epidemic. Susan Jaffe, The Lancet Washington correspondent, reports.

Published
10 November 2017
From
The Lancet (free registration required)
Ireland’s first clinic monitoring anti-HIV drug PrEP opens

The clinic will be open to users of the drug and will provide HIV tests and STI screening; it will not supply the drug.

Published
10 November 2017
From
The Irish Times
Vital Microbicides May Soon Be Out of Reach

Whether, when, and how microbicide development proceeds depends on the U.S government, and the federal Division of AIDS has suggested this development may no longer be a priority. It's wrong.

Published
10 November 2017
From
Rewire
Gilead loss of generic HIV drug battle a boost for gay community

Published
09 November 2017
From
The Irish Times
HIV Undetectable = Untransmittable: A Community Brief

The International Council of AIDS Service Organizations (ICASO) developed this brief to provide the HIV community with current information and analysis of new and updated clinical data on the effectiveness of antiretroviral therapy (ART) in preventing HIV transmission to sexual partners of people living with HIV. While the health benefits of treatment will always be the primary purpose of ART, it is vital that the secondary benefits to people living with HIV and their sexual partners be fully understood and communicated.

Published
08 November 2017
From
ICASO
HIV diagnoses in English gay men have been falling since 2014

A new analysis by Public Health England of testing rates and HIV diagnoses from all of England’s sexual health clinics shows that the decline in

Published
08 November 2017
By
Gus Cairns

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.